Axilix Drugs And Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Indore, Madhya Pradesh, India, established in 2022.
2022 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Axilix Drugs And Pharma Private Limited

Axilix Drugs And Pharma Private Limited, a active private limited company, was established on 30 May 2022 in Indore, Madhya Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230MP2022PTC061140. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Dawar Khan (Additional Director), Rashid Patel (Director). Past directors included Mukesh Kumar Jain. It is based at Pearl Villa 69, Ab Bypass Road Silver Spring Phase 1, Mundla Nayata, Indore, Madhya Pradesh, 452020.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MP2022PTC061140

  • Registration Number

    061140

  • Incorporation Date

    30 May 2022

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Year, 9 Months
Company report

Axilix Drugs And Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Axilix Drugs And Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Axilix Drugs And Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Dawar Khan Additional Director 17 Oct 2022 Current
Rashid Patel Director 30 May 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 17 Oct 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Axilix Drugs And Pharma.

Enhance accessibility to Axilix Drugs And Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Axilix Drugs And Pharma revenue growth over time
Axilix Drugs And Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Axilix Drugs And Pharma?

Unlock access to Axilix Drugs And Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Axilix Drugs And Pharma?

Axilix Drugs And Pharma has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Axilix Drugs And Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axilix Drugs And Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Axilix Drugs And Pharma
Recent Activity within the Organization
  • Director Appointment

    Dawar Khan was appointed as a Additional Director was appointed as a Additional Director on 17 Oct 2022 & has been associated with this company since 3 years 4 months . was recorded as a recent event.

  • Director Appointment

    The activity Rashid Patel was appointed as a Director was appointed as a Director on 30 May 2022 & has been associated with this company since 3 years 9 months . was completed.

  • Company Incorporation

    The activity Axilix Drugs And Pharma Private Limited was registered on 30 May 2022 with Roc Gwalior & aged 3 years 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Axilix Drugs And Pharma Private Limited?

The CIN of Axilix Drugs And Pharma Private Limited is U24230MP2022PTC061140.

Where is Axilix Drugs And Pharma Private Limited headquartered?

Axilix Drugs And Pharma Private Limited is headquartered at Pearl Villa 69, Ab Bypass Road Silver Spring Phase 1, Mundla Nayata, Indore, Madhya Pradesh, 452020.

When was Axilix Drugs And Pharma Private Limited incorporated?

Axilix Drugs And Pharma Private Limited was incorporated on 30 May 2022.

Who are the current directors of Axilix Drugs And Pharma Private Limited?

The current directors of Axilix Drugs And Pharma Private Limited are

What is the primary industry of Axilix Drugs And Pharma Private Limited?

The primary industry of Axilix Drugs And Pharma Private Limited is Chemicals.

Is Axilix Drugs And Pharma Private Limited a listed company?

Axilix Drugs And Pharma Private Limited is unlisted.

What is the capital structure of Axilix Drugs And Pharma Private Limited?

The authorized capital of Axilix Drugs And Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available